Page last updated: 2024-08-24

topotecan and Carcinogenesis

topotecan has been researched along with Carcinogenesis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aroonroch, R; Boontawon, T; Chaitankar, V; Chittavanich, P; Hongeng, S; Jinawath, N; Kaewkhaw, R; Rojanaporn, D; Saengwimol, D; Thammachote, W1
Bernhardt, G; Brockhoff, G; Buschauer, A; Huber, S; Wege, AK1

Other Studies

2 other study(ies) available for topotecan and Carcinogenesis

ArticleYear
A three-dimensional organoid model recapitulates tumorigenic aspects and drug responses of advanced human retinoblastoma.
    Scientific reports, 2018, 10-23, Volume: 8, Issue:1

    Topics: Antineoplastic Agents; Carcinogenesis; Child, Preschool; DNA Copy Number Variations; Gene Expression Regulation, Neoplastic; Humans; Infant; Melphalan; Models, Biological; Neoplasm Staging; Organoids; Retinal Neoplasms; Retinoblastoma; Topotecan

2018
Topotecan-induced ABCG2 expression in MCF-7 cells is associated with decreased CD24 and EpCAM expression and a loss of tumorigenicity.
    Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2015, Volume: 87, Issue:8

    Topics: Animals; Antigens, Neoplasm; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Carcinogenesis; CD24 Antigen; Cell Adhesion Molecules; Cell Line, Tumor; Epithelial Cell Adhesion Molecule; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mice; Mice, Nude; Neoplasm Proteins; Receptor, ErbB-2; Topotecan

2015